These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24004603)

  • 1. Molecular mechanism of the camptothecin resistance of Glu710Gly topoisomerase IB mutant analyzed in vitro and in silico.
    Tesauro C; Morozzo della Rocca B; Ottaviani A; Coletta A; Zuccaro L; Arnò B; D'Annessa I; Fiorani P; Desideri A
    Mol Cancer; 2013 Sep; 12(1):100. PubMed ID: 24004603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human topoisomerase 1B Arg634Ala mutation results in camptothecin resistance and loss of inter-domain motion correlation.
    D'Annessa I; Tesauro C; Wang Z; Arnò B; Zuccaro L; Fiorani P; Desideri A
    Biochim Biophys Acta; 2013 Dec; 1834(12):2712-21. PubMed ID: 24096022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Topoisomerase I mutations are associated with resistance to camptothecin.
    Gongora C; Vezzio-Vie N; Tuduri S; Denis V; Causse A; Auzanneau C; Collod-Beroud G; Coquelle A; Pasero P; Pourquier P; Martineau P; Del Rio M
    Mol Cancer; 2011 May; 10():64. PubMed ID: 21619602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of Gly717Phe in human topoisomerase 1B has an effect on enzymatic function, reactivity to the camptothecin anticancer drug and on the linker domain orientation.
    Wang Z; D'Annessa I; Tesauro C; Croce S; Ottaviani A; Fiorani P; Desideri A
    Biochim Biophys Acta; 2015 Aug; 1854(8):860-8. PubMed ID: 25910424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.
    Fiorani P; Bruselles A; Falconi M; Chillemi G; Desideri A; Benedetti P
    J Biol Chem; 2003 Oct; 278(44):43268-75. PubMed ID: 12904303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human DNA topoisomerase I mutant Gly717Asp: Higher religation rate is not always associated with camptothecin resistance.
    Wang Z; D'Annessa I; Tesauro C; Ottaviani A; Soren BC; Dasari JB; Messina B; Thareparambil A; Fiorani P
    Arch Biochem Biophys; 2019 Mar; 663():165-172. PubMed ID: 30653963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers.
    Tesauro C; Graziani G; Arnò B; Zuccaro L; Muzi A; D'Annessa I; Santori E; Tentori L; Leonetti C; Fiorani P; Desideri A
    J Exp Clin Cancer Res; 2014 Sep; 33(1):71. PubMed ID: 25227992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin.
    van der Merwe M; Bjornsti MA
    J Biol Chem; 2008 Feb; 283(6):3305-3315. PubMed ID: 18056711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.
    Arnò B; D'Annessa I; Tesauro C; Zuccaro L; Ottaviani A; Knudsen B; Fiorani P; Desideri A
    PLoS One; 2013; 8(7):e68404. PubMed ID: 23844196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight of DNA topoisomerases I from camptothecin-producing plants revealed by molecular dynamics simulations.
    Sirikantaramas S; Meeprasert A; Rungrotmongkol T; Fuji H; Hoshino T; Sudo H; Yamazaki M; Saito K
    Phytochemistry; 2015 May; 113():50-6. PubMed ID: 25733498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality.
    Losasso C; Cretaio E; Palle K; Pattarello L; Bjornsti MA; Benedetti P
    J Biol Chem; 2007 Mar; 282(13):9855-9864. PubMed ID: 17276985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cells.
    Arakawa Y; Suzuki H; Saito S; Yamada H
    Mol Cancer Ther; 2006 Mar; 5(3):502-8. PubMed ID: 16546964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of camptothecin resistance by human topoisomerase I mutations.
    Chrencik JE; Staker BL; Burgin AB; Pourquier P; Pommier Y; Stewart L; Redinbo MR
    J Mol Biol; 2004 Jun; 339(4):773-84. PubMed ID: 15165849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations.
    Chillemi G; D'Annessa I; Fiorani P; Losasso C; Benedetti P; Desideri A
    Nucleic Acids Res; 2008 Oct; 36(17):5645-51. PubMed ID: 18765473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.
    Knab AM; Fertala J; Bjornsti MA
    J Biol Chem; 1995 Mar; 270(11):6141-8. PubMed ID: 7890748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay.
    Stewart L; Ireton GC; Champoux JJ
    J Biol Chem; 1999 Nov; 274(46):32950-60. PubMed ID: 10551862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB.
    Soren BC; Babu Dasari J; Ottaviani A; Messina B; Andreotti G; Romeo A; Iacovelli F; Falconi M; Desideri A; Fiorani P
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.
    Fiorani P; Amatruda JF; Silvestri A; Butler RH; Bjornsti MA; Benedetti P
    Mol Pharmacol; 1999 Dec; 56(6):1105-15. PubMed ID: 10570037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.
    Champoux JJ
    Ann N Y Acad Sci; 2000; 922():56-64. PubMed ID: 11193925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.
    Mancini G; D'Annessa I; Coletta A; Sanna N; Chillemi G; Desideri A
    PLoS One; 2010 Jun; 5(6):e10934. PubMed ID: 20532182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.